David Watson - General Counsel at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Stock Symbol
APLS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

David Watson - trading volume in the past year for Apellis Pharmaceuticals, Inc.

Holdings reported by David Watson for Apellis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 109K $2.18M $20.06 Nov 17, 2025 Direct
Stock Option (Right to Buy) 82.5K $1.6M $19.39 Jun 9, 2025 Direct Common Stock
Common Stock 50.1K $1.42M $28.31 Nov 17, 2025 Indirect Owner (The David O. Watson Irrevocable Trust of 2023)
Common Stock 10K $283K $28.31 Nov 17, 2025 Indirect Owner (Custodial Account for minor children)

Transactions reported by David Watson for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.